View monthly record counts
| Month | Records |
|---|---|
| 1 | |
| 1 |
Data updated:
| Month | Records |
|---|---|
| 1 | |
| 1 |
| # | Country / Region | Records |
|---|---|---|
| 1 | Nigeria | 2 |
| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 300439 | 未列名含有激素或品目29.37其他产品的药品,已配定剂量或制成零售包装 | Medicaments containing hormones or steroids used as hormones but not antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excluding medicaments containing insulin or corticosteroid hormones, their derivatives or structural analogues) | 1 |
| 2 | 300490 | 其他混合或非混合产品构成的药品,已配定剂量或制成零售包装 | Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | 1 |
| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | PATBLESS PHARMACEUTICAL LTD | NIGERIA | 1 |
| 2 | T. P. DRUGS LIMITED | — | 1 |
| Date | Feb 18, 2025 | Bill No. | — | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | IMPLUSE PHARMA PVT LTD | Buyer Information | Company Name | PATBLESS PHARMACEUTICAL LTD |
| Address | — | Address | — | ||
| Registration No. | — | Registration No. | 20557889 0001 | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30049090 | HS Description | 其他混合或非混合产品构成的药品,已配定剂量或制成零售包装Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | |
| Product Description | OSMIN TABLET (DICLOFENAC TABLETS) | Brand | — | ||
| Quantity & Price | Amount | 40,227.57 | Weight | 21,390 kg | |
| Quantity | — | TEU | — | ||
| Shipment Information | Origin Country | INDIA | Destination Country | NIGERIA | |
| Port of Loading | — | Destination Port | — | ||
| Loading Place | — | Transport Mode | UNKNOWN | ||
| Transaction Mode | — | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | BEAU6349173 45G1 | Shipping Country | — | ||